Animal models of chronic obstructive pulmonary disease

Expert Opinion on Drug Discovery

Volumn 9, Issue 6, 2014, Pages 629-645

  Fricker, Michael ^a   Deane, Andrew ^a   Hansbro, Philip M ^a  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Animal model; Chemokine; Chronic obstructive pulmonary disease; Cigarette; Cytokine; Emphysema; Guinea pig; Immune system; Inflammation; Lung; Lymphocyte; Macrophage; Mast cell; Model; Mouse; Neutrophil; Oxidative stress; Protease; Pulmonary; Rat

Indexed keywords

CHEMOKINE; CIGARETTE SMOKE; CYTOKINE;

AGE; AIRWAY REMODELING; ANIMAL MODEL; BACTERIUM; CACHEXIA; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE EXACERBATION; EMPHYSEMA; GENDER; GUINEA PIG; IMMUNOCOMPETENT CELL; INFLUENZA; LUNG FUNCTION; MORBIDITY; MORTALITY; MOUSE; MUCUS; NONHUMAN; OSTEOPOROSIS; OXIDATIVE STRESS; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; REVIEW; RISK FACTOR; SMOKING CESSATION; SPECIES; VIRUS; ANIMAL; DISEASE MODEL; HUMAN; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; MICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 84901254158     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2014.909805     Document Type: Review

References (143)

1. Global initiative for chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. Available from: Http://www.goldcopdorg/2013
2. World Health Organisation. The global burden of disease: 2004 update. 2004. Available from: Http://www.hoint/ healthinfo/global-burden-disease/ 2004-report-update/en/indexhtml
3. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;15;380(9859): 2095-128
4. Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Resp Med 2013;1(1):73-83
5. Barnes PJ. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat Rev Drug Discov 2013;12(7):543-59
6. Bauer CM, Morissette MC, Stampfli MR. The influence of cigarette smoking on viral infections: Translating bench science to impact COPD pathogenesis and acute exacerbations of COPD clinically. Chest 2013;143(1):196-206
7. Wedzicha JA, Seemungal TA. COPD exacerbations: Defining their cause and prevention. Lancet 2007;370(9589):786-96 (Pubitemid 47320802
8. Keely S, Talley NJ, Hansbro PM. Pulmonary-intestinal cross-Talk in mucosal inflammatory disease. Mucosal Immunol 2012;5(1):7-18
9. Hansen MJ, Gualano RC, Bozinovski S, et al. Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease). Pharmacol Ther 2006;109(1-2):162-72 (Pubitemid 41740819
10. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008;295(1):L1-15
11. Thorburn AN, Foster PS, Gibson PG, Hansbro PM. Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells. J Immunol 2012;188(9):4611-20
12. Essilfie AT, Simpson JL, Dunkley ML, et al. Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 2012;67(7):588-99
13. Starkey MR, Jarnicki AG, Essilfie AT, et al. Murine models of infectious exacerbations of airway inflammation. Curr Opin Pharmacol 2013;13(3):337-44
14. Leberl M, Kratzer A, Taraseviciene-Stewart L. Tobacco smoke induced COPD/emphysema in the animal model-Are we all on the same page? Front Physiol 2013;4:91
15. Moritsugu KP. The 2006 Report of the Surgeon General: The health consequences of involuntary exposure to tobacco smoke. Am J Prev Med 2007;32(6):542-3
16. Wright JL, Churg A. Cigarette smoke causes physiologic and morphologic changes of emphysema in the guinea pig. Am Rev Respir Dis 1990;142(6 Pt 1):1422-8
17. Wright JL, Sun JP. Effect of smoking cessation on pulmonary and cardiovascular function and structure: Analysis of guinea pig model. J Appl Physiol 1994;76(5):2163-8 (Pubitemid 24158652
18. Selman M, Montano M, Ramos C, et al. Tobacco smoke-induced lung emphysema in guinea pigs is associated with increased interstitial collagenase. Am J Physiol 1996;271(5 Pt 1):L734-43
19. Wright JL, Farmer SG, Churg A. Synthetic serine elastase inhibitor reduces cigarette smoke-induced emphysema in guinea pigs. Am J Respir Crit Care Med 2002;166(7):954-60 (Pubitemid 35193225
20. Golovatch P, Mercer BA, Lemaitre V, et al. Role for cathepsin K in emphysema in smoke-exposed guinea pigs. Exp Lung Res 2009;35(8):631-45
21. Dominguez-Fandos D, Peinado VI, Puig-Pey R, et al. Pulmonary inflammatory reaction and structural changes induced by cigarette smoke exposure in the Guinea pig. COPD 2012;9(5):473-84
22. Wright JL, Postma DS, Kerstjens HA, et al. Airway remodeling in the smoke exposed guinea pig model. Inhal Toxicol 2007;19(11):915-23 (Pubitemid 350112226
23. Wright JL, Churg A. Smoke-induced emphysema in guinea pigs is associated with morphometric evidence of collagen breakdown and repair. Am J Physiol 1995;268(1 Pt 1):L17-20
24. Wright JL, Ngai T, Churg A. Effect of long-Term exposure to cigarette smoke on the small airways of the guinea pig. Exp Lung Res 1992;18(1):105-14
25. Wright JL, Churg A. Smoking cessation decreases the number of metaplastic secretory cells in the small airways of the Guinea pig. Inhal Toxicol 2002;14(11):1153-9 (Pubitemid 35334429
26. Ardite E, Peinado VI, Rabinovich RA, et al. Systemic effects of cigarette smoke exposure in the guinea pig. Respir Med 2006;100(7):1186-94 (Pubitemid 44207849
27. Wright JL, Zhou S, Preobrazhenska O, et al. Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling. Am J Respir Crit Care Med 2011;183(1):50-8
28. Ofulue AF, Ko M, Abboud RT. Time course of neutrophil and macrophage elastinolytic activities in cigarette smoke-induced emphysema. Am J Physiol 1998;275(6 Pt 1): L1134-44
29. Ofulue AF, Ko M. Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. Am J Physiol 1999;277(1 Pt 1):L97-105
30. Lee JH, Lee DS, Kim EK, et al. Simvastatin inhibits cigarette smokinginduced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med 2005;172(8):987-93
31. Roh GS, Yi CO, Cho YJ, et al. Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema. Am J Physiol Lung Cell Mol Physiol 2010;299(2):L184-91
32. Kratzer A, Salys J, Nold-Petry C, et al. Role of IL-18 in second-hand smokeinduced emphysema. Am J Respir Cell Mol Biol 2013;48(6):725-32
33. Wang L, Yang J, Guo L, et al. Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2012;46(5):614-22
34. Vlahos R, Bozinovski S. Recent advances in pre-clinical mouse models of COPD. Clin Sci (Lond) 2014;126(4):253-65
35. Moriyama C, Betsuyaku T, Ito Y, et al. Aging enhances susceptibility to cigarette smoke-induced inflammation through bronchiolar chemokines. Am J Respir Cell Mol Biol 2010;42(3):304-11
36. Gould NS, Min E, Gauthier S, et al. Aging adversely affects the cigarette smoke-induced glutathione adaptive response in the lung. Am J Respir Crit Care Med 2010;182(9):1114-22
37. Zhou S, Wright JL, Liu J, et al. Aging does not Enhance Experimental Cigarette Smoke-Induced COPD in the Mouse. PLoS One 2013;8(8):e71410
38. March TH, Wilder JA, Esparza DC, et al. Modulators of cigarette smokeinduced pulmonary emphysema in A/J mice. Toxicol Sci 2006;92(2):545-59 (Pubitemid 44018971
39. Cavarra E, Bartalesi B, Lucattelli M, et al. Effects of cigarette smoke in mice with different levels of alpha(1)-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med 2001;1;164(5):886-90
40. Rangasamy T, Cho CY, Thimmulappa RK, et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004;114(9):1248-59 (Pubitemid 40385296
41. Bartalesi B, Cavarra E, Fineschi S, et al. Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants. Eur Respir J 2005;25(1):15-22 (Pubitemid 40207726
42. Foronjy RF, Mercer BA, Maxfield MW, et al. Structural emphysema does not correlate with lung compliance: Lessons from the mouse smoking model. Exp Lung Res 2005;31(6):547-62 (Pubitemid 40967241
43. March TH, Bowen LE, Finch GL, et al. Effects of strain and treatment with inhaled aII-Trans-retinoic acid on cigarette smoke-induced pulmonary emphysema in mice. COPD 2005;2(3):289-302 (Pubitemid 43879445
44. Guerassimov A, Hoshino Y, Takubo Y, et al. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am J Respir Crit Care Med 2004;170(9):974-80 (Pubitemid 39425693
45. Hodge-Bell KC, Lee KM, Renne RA, et al. Pulmonary inflammation in mice exposed to mainstream cigarette smoke. Inhal Toxicol 2007;19(4):361-76 (Pubitemid 46294849
46. Beckett EL, Stevens RL, Jarnicki AG, et al. A new short-Term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J Allergy Clin Immunol 2013;131(3):752-62
47. Nakanishi Y, Kobayashi D, Asano Y, et al. Clarithromycin prevents smokeinduced emphysema in mice. Am J Respir Crit Care Med 2009;179(4):271-8
48. Braber S, Henricks PA, Nijkamp FP, et al. Inflammatory changes in the airways of mice caused by cigarette Animal models of COPD Expert Opin. Drug Discov. (2014) 9(6) 641
49. Churg A, Zhou S, Wang X, et al. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol 2009;40(4):482-90
50. Chen L, Lai K, Lomask JM, et al. Detection of mouse cough based on sound monitoring and respiratory airflow waveforms. PLoS One 2013;8(3):e59263
51. Barnes PJ. Alveolar macrophages as orchestrators of COPD. COPD 2004;1(1):59-70
52. Brusselle GG. Matrix metalloproteinase 12, asthma, and COPD. N Engl J Med 2009;361(27):2664-5
53. Dhami R, Gilks B, Xie C, et al. Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by alpha1-Antitrypsin. Am J Respir Cell Mol Biol 2000;22(2):244-52 (Pubitemid 30351488
54. Churg A, Wang RD, Tai H, et al. Tumor necrosis factor-Alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004;170(5):492-8 (Pubitemid 39209129
55. Motz GT, Eppert BL, Wortham BW, et al. Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease. J Immunol 2010;184(8):4460-9
56. Wortham BW, Eppert BL, Motz GT, et al. NKG2D mediates NK cell hyperresponsiveness and influenzainduced pathologies in a mouse model of chronic obstructive pulmonary disease. J Immunol 2012;188(9):4468-75
57. Maeno T, Houghton AM, Quintero PA, et al. CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol 2007;178(12):8090-6 (Pubitemid 46898081
58. Motz GT, Eppert BL, Wesselkamper SC, et al. Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/-mice. Am J Respir Crit Care Med 2010;181(11):1223-33
59. Eppert BL, Wortham BW, Flury JL, Borchers MT. Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary disease. J Immunol 2013;190(3):1331-40
60. Shan M, Yuan X, Song LZ, et al. Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med 2012;4(117):117-9
61. Anthony D, Seow HJ, Uddin M, et al. Serum amyloid A promotes lung neutrophilia by increasing IL-17A levels in the mucosa and gammadelta T cells. Am J Respir Crit Care Med 2013;188(2):179-86
62. Botelho FM, Nikota JK, Bauer CM, et al. Cigarette smoke-induced accumulation of lung dendritic cells is interleukin-1alpha-dependent in mice. Respir Res 2012;13:81
63. Dancer R, Sansom DM. Regulatory T cells and COPD. Thorax 2013;68(12):1176-8
64. Demoor T, Bracke KR, Joos GF, Brusselle GG. Increased T-regulatory cells in lungs and draining lymph nodes in a murine model of COPD. Eur Respir J 2010;35(3):688-9
65. Brandsma CA, Hylkema MN, Van Der Strate BW, et al. Heme oxygenase-1 prevents smoke induced B-cell infiltrates: A role for regulatory T cells? Respir Res 2008;9:17
66. Thorburn AN, Hansbro PM. Harnessing regulatory T cells to suppress asthma: From potential to therapy. Am J Respir Cell Mol Biol 2010;43(5):511-19
67. Scrimini S, Pons J, Agusti A, et al. Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells. Respir Med 2013;107(12):1895-903
68. Churg A, Dai J, Tai H, et al. Tumor necrosis factor-Alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002;166(6):849-54
69. D'Hulst AI, Bracke KR, Maes T, et al. Role of tumour necrosis factor-Alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. Eur Respir J 2006;28(1):102-12 (Pubitemid 44914267
70. Botelho FM, Bauer CM, Finch D, et al. IL-1alpha/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One 2011;6(12):e28457
71. Kang MJ, Homer RJ, Gallo A, et al. IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J Immunol 2007;178(3):1948-59 (Pubitemid 46154668
72. Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2009;41(6):631-8
73. Pauwels NS, Bracke KR, Maes T, et al. The role of interleukin-6 in pulmonary and systemic manifestations in a murine model of chronic obstructive pulmonary disease. Exp Lung Res 2010;36(8):469-83
74. Cicko S, Lucattelli M, Muller T, et al. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J Immunol 2010;185(1):688-97
75. Richens TR, Linderman DJ, Horstmann SA, et al. Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am J Respir Crit Care Med 2009;179(11):1011-21
76. Hodge S, Hodge G, Ahern J, et al. Smoking alters alveolar macrophage recognition and phagocytic ability: Implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2007;37(6):748-55 (Pubitemid 350211645
77. Hodge S, Matthews G, Mukaro V, et al. Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine. Am J Respir Cell Mol Biol 2011;44(5):673-81
78. Hodge S, Matthews G, Dean MM, et al. Therapeutic role for mannose-binding lectin in cigarette smoke-induced lung inflammation? Evidence from a murine model. Am J Respir Cell Mol Biol 2010;42(2):235-42
79. Vlahos R, Bozinovski S, Hamilton JA, Anderson GP. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol Ther 2006;112(1):106-15
80. Saha S, Doe C, Mistry V, et al. Granulocyte-macrophage colonystimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD. Thorax 2009;64(8):671-6
81. Clauss M, Voswinckel R, Rajashekhar G, et al. Lung endothelial monocyteactivating protein 2 is a mediator of cigarette smoke-induced emphysema in mice. J Clin Invest 2011;121(6):2470-9
82. Ma B, Kang MJ, Lee CG, et al. Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema. J Clin Invest 2005;115(12):3460-72 (Pubitemid 43121834
83. Bracke KR, D'Hulst A I, Maes T, et al. Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice. Clin Exp Allergy 2007;37(10):1467-79 (Pubitemid 47460235
84. Bracke KR, D'Hulst A I, Maes T, et al. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol 2006;177(7):4350-9 (Pubitemid 44469763
85. Demoor T, Bracke KR, Vermaelen KY, et al. CCR7 modulates pulmonary and lymph node inflammatory responses in cigarette smoke-exposed mice. J Immunol 2009;183(12):8186-94
86. Shapiro SD, Goldstein NM, Houghton AM, et al. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 2003;163(6):2329-35 (Pubitemid 37466476
87. Stevens T, Ekholm K, Granse M, et al. AZD9668: Pharmacological characterization of a novel oral inhibitor of neutrophil elastase. J Pharmacol Exp Ther 2011;339(1):313-20
88. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997;277(5334):2002-4 (Pubitemid 27449144
89. Atkinson JJ, Lutey BA, Suzuki Y, et al. The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am J Respir Crit Care Med 2011;183(7):876-84
90. Selman M, Cisneros-Lira J, Gaxiola M, et al. Matrix metalloproteinases inhibition attenuates tobacco smokeinduced emphysema in Guinea pigs. Chest 2003;123(5):1633-41 (Pubitemid 36549786
91. Churg A, Wang R, Wang X, et al. Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax 2007;62(8):706-13 (Pubitemid 47235016
92. Caramori G, Adcock IM, Casolari P, et al. Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer. Thorax 2011;66(6):521-7
93. Foronjy R, D'Armiento J. The effect of cigarette smoke-derived oxidants on the inflammatory response of the lung. Clin Appl Immunol Rev 2006;1;6(1):53-72 (Pubitemid 44201662
94. Yao H, Arunachalam G, Hwang JW, et al. Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. Proc Natl Acad Sci USA 2010;31;107(35):15571-6
95. Seimetz M, Parajuli N, Pichl A, et al. Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell 2011;14;147(2):293-305
96. Duong C, Seow HJ, Bozinovski S, et al. Glutathione peroxidase-1 protects against cigarette smoke-induced lung inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2010;299(3):L425-33
97. Churg A, Marshall CV, Sin DD, et al. Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185(1):34-43
98. Yoshida T, Mett I, Bhunia AK, et al. Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med 2010;16(7):767-73
99. Rastrick JM, Stevenson CS, Eltom S, et al. Cigarette smoke induced airway inflammation is independent of NF-kappaB signalling. PLoS One 2013;8(1):e54128
100. Sussan TE, Rangasamy T, Blake DJ, et al. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc Natl Acad Sci USA 2009;6;106(1):250-5
101. Kirkham PA, Caramori G, Casolari P, et al. Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;184(7):796-802
102. Kheradmand F, Shan M, Xu C, Corry DB. Autoimmunity in chronic obstructive pulmonary disease: Clinical and experimental evidence. Expert Rev Clin Immunol 2012;8(3):285-92
103. Wiegman CH, Li F, Clarke CJ, et al. A comprehensive analysis of oxidative stress in the ozone-induced lung inflammation mouse model. Clin Sci (Lond) 2014;126(6):425-40
104. Wedzicha JA. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1(2):115-20
105. Wedzicha JA. Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(10 Pt 1):1757-8 (Pubitemid 33152304
106. Wesseling G. Occasional review: Influenza in COPD: Pathogenesis, prevention, and treatment. Int J Chron Obstruct Pulmon Dis 2007;2(1):5-10 (Pubitemid 46915823
107. Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(9):1618-23 (Pubitemid 33124148
108. Hsu AC, See HV, Hansbro PM, Wark PA. Innate immunity to influenza in chronic airways diseases. Respirology 2012;17(8):1166-75
109. Gualano RC, Hansen MJ, Vlahos R, et al. Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice. Respir Res 2008;9:53
110. Yageta Y, Ishii Y, Morishima Y, et al. Role of Nrf2 in host defense against influenza virus in cigarette smokeexposed mice. J Virol 2011;85(10):4679-90
111. Robbins CS, Bauer CM, Vujicic N, et al. Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am J Respir Crit Care Med 2006;174(12):1342-51 (Pubitemid 44913036
112. Kang MJ, Lee CG, Lee JY, et al. Cigarette smoke selectively enhances viral PAMP-And virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 2008;118(8):2771-84
113. Zhou Y, Kang MJ, Jha BK, et al. Role of ribonuclease L in viral pathogenassociated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling. J Immunol 2013;191(5):2637-46
114. Kimura G, Ueda K, Eto S, et al. Toll-like receptor 3 stimulation causes corticosteroid-refractory airway neutrophilia and hyperresponsiveness in mice. Chest 2013;144(1):99-105
115. Kang MJ, Choi JM, Kim BH, et al. IL-18 induces emphysema and airway and vascular remodeling via IFN-gamma, IL-17A, and IL-13. Am J Respir Crit Care Med 2012;185(11):1205-17
116. Bauer CM, Zavitz CC, Botelho FM, et al. Treating viral exacerbations of chronic obstructive pulmonary disease: Insights from a mouse model of cigarette smoke and H1N1 influenza infection. PLoS One 2010;5(10):e13251
117. Feng Y, Kong Y, Barnes PF, et al. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun 2011;79(1):229-37
118. Drannik AG, Pouladi MA, Robbins CS, et al. Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2004;170(11):1164-71 (Pubitemid 39577373
119. Gaschler GJ, Skrtic M, Zavitz CC, et al. Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile. Am J Respir Crit Care Med 2009;179(8):666-75
120. Huvenne W, Lanckacker EA, Krysko O, et al. Exacerbation of cigarette smokeinduced pulmonary inflammation by Staphylococcus aureus enterotoxin B in mice. Respir Res 2011;12:69
121. Sakuma K, Yamaguchi A. Sarcopenia and cachexia: The adaptations of negative regulators of skeletal muscle mass. J Cachexia Sarcopenia Muscle 2012;3(2):77-94
122. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2008;31(3):492-501
123. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010;36(1):81-8
124. Chen H, Hansen MJ, Jones JE, et al. Long-Term cigarette smoke exposure increases uncoupling protein expression but reduces energy intake. Brain Res 2008;1228:81-8
125. Miller M, Pham A, Cho JY, et al. Adiponectin-deficient mice are protected against tobacco-induced inflammation and increased emphysema. Am J Physiol Lung Cell Mol Physiol 2010;299(6):L834-42
126. Gosker HR, Langen RC, Bracke KR, et al. Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure. Am J Respir Cell Mol Biol 2009;40(6):710-16
127. Rinaldi M, Maes K, De Vleeschauwer S, et al. Long-Term nose-only cigarette smoke exposure induces emphysema and mild skeletal muscle dysfunction in mice. Dis Model Mech 2012;5(3):333-41
128. Tang K, Wagner PD, Breen EC. TNF-Alpha-mediated reduction in PGC-1alpha may impair skeletal muscle function after cigarette smoke exposure. J Cell Physiol 2010;222(2):320-7
129. Caron MA, Morissette MC, Theriault ME, et al. Alterations in skeletal muscle cell homeostasis in a mouse model of cigarette smoke exposure. PLoS One 2013;8(6):e66433
130. De Paepe B, Brusselle GG, Maes T, et al. TNF alpha receptor genotype influences smoking-induced muscle-fibre-Type shift and atrophy in mice. Acta Neuropathol 2008;115(6):675-81
131. Romme EA, Smeenk FW, Rutten EP, Wouters EF. Osteoporosis in chronic obstructive pulmonary disease. Expert Rev Respir Med 2013;7(4):397-410
132. Akhter MP, Lund AD, Gairola CG. Bone biomechanical property deterioration due to tobacco smoke exposure. Calcif Tissue Int 2005;77(5):319-26 (Pubitemid 41704910
133. Ajiro Y, Tokuhashi Y, Matsuzaki H, et al. Impact of passive smoking on the bones of rats. Orthopedics 2010;33(2):90-5
134. Glynos C, Dupont LL, Vassilakopoulos T, et al. The role of soluble guanylyl cyclase in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188(7):789-99
135. Schweitzer KS, Johnstone BH, Garrison J, et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med 2011;183(2):215-25
136. Marwick JA, Caramori G, Stevenson CS, et al. Inhibition of PI3Kdelta restores glucocorticoid function in smokinginduced airway inflammation in mice. Am J Respir Crit Care Med 2009;179(7):542-8
137. Bozinovski S, Uddin M, Vlahos R, et al. Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 2012;17;109(3):935-40
138. Hakim A, Adcock IM, Usmani OS. Corticosteroid resistance and novel antiinflammatory therapies in chronic obstructive pulmonary disease: Current evidence and future direction. Drugs 2012;72(10):1299-312
139. Nie YC, Wu H, Li PB, et al. Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: To establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2012;25(5):349-56
140. D'Hulst A I, Vermaelen KY, Brusselle GG, et al. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005;26(2):204-13 (Pubitemid 41079063
141. Bracke KR, Verhamme FM, Seys LJ, et al. Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188(3):343-55
142. Van Der Deen M, Timens W, Timmer-Bosscha H, et al. Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice. Respir Res 2007;8:49
143. Christensen PJ, Preston AM, Ling T, et al. Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice. Infect Immun 2008;76(8):3481-90